Cargando…

Kinetics of immune cell responses in the multiple low‐dose streptozotocin mouse model of type 1 diabetes

In type 1 diabetes (T1D), the insulin‐producing β cells are destructed by immune mechanisms. It has been hypothesized that the very first immune response in T1D onset comes from innate immune cells, which further activates the adaptive immune cells to attack the islets. Despite intensive research on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Zhengkang, Soläng, Charlotte, Mejia‐Cordova, Mariela, Thorvaldson, Lina, Blixt, Martin, Sandler, Stellan, Singh, Kailash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996374/ https://www.ncbi.nlm.nih.gov/pubmed/32123849 http://dx.doi.org/10.1096/fba.2019-00031

Ejemplares similares

Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naïve mice
por: Singh, Kailash, et al.
Publicado: (2015)

Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
por: Luo, Zhengkang, et al.
Publicado: (2021)

Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
por: Li, Xiujuan, et al.
Publicado: (2018)

Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
por: Luo, Zhengkang, et al.
Publicado: (2022)

Interleukin-35 administration counteracts established murine type 1 diabetes – possible involvement of regulatory T cells
por: Singh, Kailash, et al.
Publicado: (2015)

The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control
por: Singh, Kailash, et al.
Publicado: (2017)

The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
por: He, Qi, et al.
Publicado: (2019)

Diabetic complications and prospective immunotherapy
por: Reynolds, Lewis, et al.
Publicado: (2023)

Dose-dependent progression of multiple low dose streptozotocin-induced diabetes in mice
por: Bauer, Brandon M., et al.
Publicado: (2023)

Dose-dependent progression of multiple low-dose streptozotocin-induced diabetes in mice
por: Bauer, Brandon M., et al.
Publicado: (2023)

Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis
por: Digre, Andreas, et al.
Publicado: (2017)

Taenia crassiceps Infection Attenuates Multiple Low-Dose Streptozotocin-Induced Diabetes
por: Espinoza-Jiménez, Arlett, et al.
Publicado: (2010)

The Protective Effects of CD39 Overexpression in Multiple Low-Dose Streptozotocin–Induced Diabetes in Mice
por: Chia, Joanne S.J., et al.
Publicado: (2013)

Effector Mechanisms in Low-Dose Streptozotocin-induced Diabetes
por: Lukić, Miodrag L., et al.
Publicado: (1998)

Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin
por: Lin, Marvin, et al.
Publicado: (2010)

The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model
por: Zhang, Ming, et al.
Publicado: (2008)

Testicular histopathology and phosphorylated protein changes in mice with diabetes induced by multiple-low doses of streptozotocin: An experimental study
por: Sampannang, Apichakan, et al.
Publicado: (2018)

Altered Expression of Somatostatin Receptors in Pancreatic Islets from NOD Mice Cultured at Different Glucose Concentrations In Vitro and in Islets Transplanted to Diabetic NOD Mice In Vivo
por: Ludvigsen, Eva, et al.
Publicado: (2011)

Glucose- and Hormone-Induced cAMP Oscillations in α- and β-Cells Within Intact Pancreatic Islets
por: Tian, Geng, et al.
Publicado: (2011)

The H1-receptor antagonist cetirizine ameliorates high-fat diet-induced glucose intolerance in male C57BL/6 mice, but not diabetes outcome in female non-obese diabetic (NOD) mice
por: Anvari, Ebrahim, et al.
Publicado: (2015)

Leucine–glycine and carnosine dipeptides prevent diabetes induced by multiple low‐doses of streptozotocin in an experimental model of adult mice
por: Vahdatpour, Tohid, et al.
Publicado: (2019)

SAT073 β Cell FFA2 Deficiency Suppresses Multiple Low Dose Streptozotocin (MLDS) Induced Diabetes
por: Xu, Kai, et al.
Publicado: (2023)

Pentoxifylline Prevents Autoimmune Mediated Inflammation in Low Dose Streptozotocin Induced Diabetes
por: Stošić-Grujičić, Stanislava D., et al.
Publicado: (2001)

Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
por: Ryu, Youngjae, et al.
Publicado: (2021)

NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin
por: Scantlebery, Angelique M. L., et al.
Publicado: (2019)

Comparison of the response using ICR mice derived from three different sources to multiple low-dose streptozotocin-induced diabetes mellitus
por: Lee, Do Yeon, et al.
Publicado: (2017)

Characterization of Mechanical Allodynia and Skin Innervation in a Mouse Model of Type-2 Diabetes Induced by Cafeteria-Style Diet and Low-Doses of Streptozotocin
por: Castañeda-Corral, Gabriela, et al.
Publicado: (2021)

Somatostatin receptor 1–5; expression profiles during rat development
por: Ludvigsen, Eva, et al.
Publicado: (2015)

Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization
por: Wang, Faxi, et al.
Publicado: (2019)

Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse
por: Li, Xiaoyan, et al.
Publicado: (2022)

Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice
por: Brahma, Manoja K., et al.
Publicado: (2022)

Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
por: Singh, Kailash, et al.
Publicado: (2022)

Verification That Mouse Chromosome 14 Is Responsible for Susceptibility to Streptozotocin in NSY Mice
por: Babaya, Naru, et al.
Publicado: (2018)

Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
por: Wahono, Aditya Mahardika, et al.
Publicado: (2023)

The Impact of Low-Dose Insulin on Peripheral Nerve Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats
por: Sugimoto, Kazuhiro, et al.
Publicado: (2013)

Ethanolic extracts of Pluchea indica (L.) leaf pretreatment attenuates cytokine-induced β-cell apoptosis in multiple low-dose streptozotocin-induced diabetic mice
por: Nopparat, Jongdee, et al.
Publicado: (2019)

Treatment with Pluchea indica (L.) Less. leaf ethanol extract alleviates liver injury in multiple low-dose streptozotocin-induced diabetic BALB/c mice
por: Nopparat, Jongdee, et al.
Publicado: (2020)

iNOS-Dependent Increase in Colonic Mucus Thickness in DSS-Colitic Rats
por: Schreiber, Olof, et al.
Publicado: (2013)

Embelia ribes extract reduces high fat diet and low dose streptozotocin-induced diabetic nephrotoxicity in rats
por: Chaudhari, Hemantkumar Somabhai, et al.
Publicado: (2013)

Both sexes develop DKD in the CD1 uninephrectomized streptozotocin mouse model
por: Trink, Jackie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pgcqoqjcjkucffm95ur6q9hb6l